The Benefits of Continuous CO2 and O2 Monitoring in the NICU
Continuous measurement of oxygenation and ventilation status detects sudden changes in the respiratory status in the fragile neonate. Premature and critically ill babies in the NICU are fragile and at risk of sudden changes in oxygenation (pO2) and carbon dioxide (pCO2) levels which can cause severe complications.
Transcutaneous monitoring in neonates provides a real-time overview of the patient’s often fluctuating oxygenation (tcpO2) and ventilation (tcpCO2) status. During this webinar, Dr. Olivier Danhaive will describe the main indications for monitoring in the NICU, including:
- High Frequency Oscillatory Ventilation
- Clinical benefits of transcutaneous monitoring (TCM) as part of Neonatal Blood Mangement (including other technologies like EtCO2, spO2 and Blood Gas), in terms of patient safety and accuracy
- and, most importantly, the interpretation of transcutaneous values in different clinical cases.
This webinar will:
- Discuss the characteristics and indications of using Transcutaneous Monitoring (TC) in the NICU
- Compare TC monitoring application, indication and effectiveness to other technologies like EtCO2, SpO2 and Blood Gas
- Using clinical cases, examine the interpretation of TC results and corresponding actions physicians can take
Olivier Danhaive, MD Professor of Pediatrics University of California San Francisco, Director of the Infant Care Center, Zuckerberg San Francisco General Hospital.
Olivier Danhaive, M.D. is an American Academy of Pediatrics board-certified neonatologist and a professor of Pediatrics at University of California San Francisco. He completed his Pediatrics residency at the Catholic University of Louvain in Brussels, Belgium and Neonatal-Perinatal Medicine fellowship at Harvard University.
One of his main clinical focuses is the respiratory management of the neonate with acute and chronic lung disease. His research interests reside in the genetics of lung development and diseases such as congenital surfactant deficiencies, bronchopulmonary dysplasia and pulmonary hypertension.
Who Should Attend?
- Respiratory therapists
- Nursing Leadership Teams
- This program has been approved for 1 CRCE Contact Hour by the American Association for Respiratory Care (AARC)
- General certificate of attendance